PKHD1L1
protein-codingPKHD1 like 1, the group of IPT domain containing
Gene summary
Predicted to enable signaling receptor activity. Predicted to be involved in immune response. Predicted to act upstream of or within sensory perception of sound. Predicted to be located in cytosol; membrane; and obsolete extracellular space. Implicated in autosomal recessive nonsyndromic deafness. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~174.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0968981
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0020678
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PKHD1L1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_177531.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 10 | 2 | 18 | ||
| missense | 2 | 1 | 653 | 51 | 4 | 711 |
| nonsense | 1 | 9 | 4 | 2 | 16 | |
| start loss | 0 | |||||
| frameshift | 1 | 7 | 5 | 13 | ||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 1 | 10 | ||
| Total | 4 | 18 | 676 | 64 | 6 | 768 |
Highest pathogenic variant AF is 0.00034767887
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_803875.2 | 78 | MANE Select | |
| Ensembl | ENSP00000367655.5 | 78 | MANE Select | |
| Ensembl | ENSP00000437376.1 | 24 | Standard | |
| Ensembl | ENSP00000667205.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- immune response
Molecular Function
- signaling receptor activity
Cellular Component
- extracellular space
- cytosol
- cilium
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378402
- Coding exons
- 78
- Length
- 167854
- Individuals with no LoFs
- 105692
- Homozygous LoFs
- 1486
- Heterozygous LoFs
- 17698
- Defined
- 124876
- p
- 0.0800
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.719 | 2145 | 2.05e+3 | 1.04 | 0.000100 | 27569 |
| Missense (PolyPhen) | 586 | 583.56 | 1.0042 | 7591 | ||
| Synonymous | -0.630 | 757 | 735 | 1.03 | 0.0000383 | 8193 |
| Loss of Function | 0.857 | 174 | 187 | 0.932 | 0.00000959 | 2493 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.019 | 0.018 | notable |
| Latino/Admixed American | 0.27 | 0.25 | notable |
| Ashkenazi Jewish | 0.017 | 0.017 | notable |
| East Asian | 0.025 | 0.024 | notable |
| Finnish | 0.073 | 0.072 | notable |
| European (Non-Finnish) | 0.065 | 0.064 | notable |
| South Asian | 0.067 | 0.064 | notable |
| Other | 0.072 | 0.069 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.0530
- RVIS EVS
- 5.45
- RVIS percentile EVS
- 99.85
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.108
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |